
Results 1 - 20 of 38 in Barr Laboratories
Market Report / TA-25 up 1.2% for the day, 0.7% for the week
Tel Aviv stocks rose strongly on the last trading day of the week yesterday. The optimism on the Tel Aviv Stock Exchange took over in the footsteps of Wall Street the day before and major European markets yesterday. Comment?
Birth Control Lawsuits Affecting Memphians
... some women - " have been tough to miss. The birth control pills are manufactured by Bayer Healthcare and Barr Laboratories. Meanwhile, Memphis-based personal injury firm Nahon, Saharovich & Trotz PLC has seen "several dozen cases and we get more ... Comment?
Cephalon Settles Barr Challenge
Analyst Report ) announced that it has settled its patent infringement case with Barr Pharmaceuticals, which is now owned by Teva Pharmaceutical . Comment?
Emergency contraception: coming soon to a teenager near you
w/Photo
As you may remember, last month a judge ordered the FDA to begin distributing Plan B, the morning-after pill, over the counter to women ages 17 and up. Comment?
Cephalon, Barr Settle Fentora Dispute
Cephalon Inc. will give Barr Pharmaceuticals Inc. a license to sell a generic version of the pain drug Fentora in 2018 as part of a patent lawsuit settlement, according to a Securities and Exchange Commission filing Thursday. Comment?
Cephalon, Inc., Barr Pharmaceuticals, Inc. Settle Patent Infringement Suit
Cephalon Inc said on Thursday it has come to an agreement to settle its patent infringement dispute with Barr Pharmaceuticals over the pain drug Fentora. Read at Reuters Comment?
Nice Quarter, Teva. What Will You Buy Next?
Sometimes, using equity to grow can come back to bite you . Teva Pharmaceuticals ' acquisition of Barr Pharmaceuticals helped boost its net income in the third quarter, but its earnings per share fell as that larger pie was split into a greater number of pieces. Comment?
Dextroamphetamine, Amphetamine 20mg Tablets
Dextroamphetamine Saccharate/Amphetamine Aspartate/Dextroamphetamine Sulfate/Amphetamine Sulfate Barr Laboratories, Inc. Comment?
Covidien gets approval for generic pain drug Actiq
w/Photo
Covidien PLC said Friday it expects to start selling a generic version of the painkiller Actiq in early 2010. Comment?
Watson and Barr Settle Lawsuit Over Oxytrol
... company, announced today that its subsidiary Watson Laboratories, Inc. has reached a settlement with Barr Laboratories, Inc. on outstanding patent litigation related to Watson's Oxytrol (Oxybutynin Transdermal System, 3.9mg/24hr.) product. On August ... Comment?
Watson and Barr Settle Lawsuit Over Oxytrol
... company, announced today that its subsidiary Watson Laboratories, Inc. has reached a settlement with Barr Laboratories, Inc. on outstanding patent litigation related to Watson's Oxytrol@ (Oxybutynin Transdermal System, 3.9mg/24hr.) product. On ... Comment?
U.S. Court of Appeals Enforces Subpoenas in FTCa s Androgel...
The Federal Trade Commission today announced two subpoena enforcement actions challenging tactics that delay agency investigations. Comment?
Sun Pharma backs out of Forest patent row
... that faced the lawsuit include Cobalt Laboratories, Teva Pharmaceuticals, Upsher-Smith Laboratories and Barr Laboratories. These companies had applied to USFDA to obtain the manufacturing and marketing approval for adamantane (Namenda). Forest Labs ... Comment?
Joseph G. Darling and Scott E. Coleridge Join Serica Technologies' Board of Directors
... of Kingston Diagnostics, developer of the first whole-blood cholesterol test. After the sale of FEI to Barr Laboratories in 2005, Mr. Coleridge joined Morningside Technology Advisory, LLC working on Healthcare and Life Science Investments. He is a ... Comment?
Teva (TEVA): Baby-boomers give boost to generics
Filed under: International markets , Newsletters , Teva Pharm Indus ADR , Stocks to Buy , Israel , Obama Picks "The health care picks in our growth portfolio should prosper whatever the outcome of the raging health care debate," suggests growth stock specialist Stephen Leeb . Comment?
Morning-after pill sales jump as U.S. access eases
Sales of the Plan B "morning-after pill" nearly doubled in the past year, exceeding expectations after the U.S. government allowed adults to buy the emergency contraceptive without a prescription. Comment?
Research and Markets: Partnering in the Global Generics Industry...
Research and Markets: Partnering in the Global Generics Industry 2009: a Guide to Companies - Now Available Identify merger, acquisition and partner candidates in the rapidly changing global generics market and collaboration runs throughout the generic industry. Comment?
Shire and Sandoz Settle Adderall XR Patent Suits
... are valid and enforceable. Shire has already entered similar settlements with Impax Laboratories Inc. and Barr Laboratories, a unit of Teva Pharmaceutical Industries Ltd. It said there are no remaining patent challenges related to generic versions ... Comment?
Shire settles pending Adderall XR litigation with Sandoz
... XR(R). No payments to Sandoz are involved in the settlement agreement. Impax Pharmaceuticals Inc. and Barr Laboratories Inc. remain the only authorized generic supplier of ADDERALL XR. The litigation involves a patent infringement lawsuit covering ... Comment?
Shire and Sandoz Settle all Pending Litigation Concerning Adderall XR
... XR(R). No payments to Sandoz are involved in the settlement agreement. Impax Pharmaceuticals Inc. and Barr Laboratories Inc. remain the only authorized generic supplier of ADDERALL XR. The litigation involves a patent infringement lawsuit covering ... Comment?